🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Antibody reliability is a huge issue, and recombinant antibodies can help. “They’re much more reproducible, you can standardize the process for them, and the user feedback is very positive,” says IPI’s Rob Meijers in a nature article published this week ➡️

Take a look at this wonderfully comprehensive video from Quanta Magazine — shows the significance of advances in #computationalproteindesign and #proteinstructureprediction, as recognized with the 2024 Nobel Prize in Chemistry! youtube.com/watch?v=cx7l9Z…

Deb Moshinsky’s no-stone-left-unturned approach to quality control is raising the bar for #antibody production at IPI, and in the wider the #antibodyreagent space. Find out more about her story and how she’s bettering IPI ➡️ proteininnovation.org/2024/10/debora…

Virtual seminar alert 📣📣 Tomorrow at 2 p.m. ET Sean Johnson (New England Biolabs) joins us for an #IPISeminar on how to use #computationalmethods to explore the natural and non-natural #protein space. Find the link on our events calendar ➡️ calendar.google.com/calendar/u/0/e…

This nature article did a great job capturing both the problems and potential solutions in finding and developing reliable, reproducible antibodies. We’re happy to be part of the piece. Read it here! nature.com/articles/d4158…

The brain is full of mysteries — like how glypican proteins act in axon guidance, synapse organization and neuron migration. “They regulate so many processes … we’ve only seen the tip of the iceberg,” says Daniel del Toro (@UBNeuroscience). Read more ➡️ proteininnovation.org/2024/11/glypic…

The Baker Lab @UWProteinDesign recently hosted this powerful webinar on computational protein design. Take a journey through the history of this groundbreaking field, guided by some of the greats! youtube.com/live/BuJGTn7Oh…

Throwback to our fall platform retreat in Essex Woods. We’re feeling especially grateful this week that we get to do science with such smart and hilarious colleagues!

New #antibody release: our anti-#glypicans are now available! Order IPI’s unconjugated #recombinant GPC1, GPC3 & GPC4 antibodies through Addgene today! proteininnovation.org/glypican-antib…

Driving commercial development at a research institute requires the ability to fuse profit & nonprofit drivers. Mike Walden, IPI’s director of commercialization, sees a unique opportunity to build something extraordinary. Find out how in our profile! proteininnovation.org/2024/12/michae…

Check out this Specifica AI challenge (co-authored by André Teixeira, now at IPI) on #antibody affinity maturation, #affinity rank prediction for Ab discovery, and computational antibody design! @NatureBiotechl #proteinscience nature.com/articles/s4158…

Fill your (lab) stockings with IPI #antibodies! 🧪🧪 Our #glypican, #integrin & #epitopetag antibodies are now available. And by purchasing from IPI, a #nonprofit protein science lab, it’s really the gift that keeps on giving! proteininnovation.org/protein-resour…